Unequal tissue expression of proteins from the PA/PAI system, myoma necrosis, and uterus survival after uterine artery occlusion

International Journal of Gynecology and Obstetrics

Volumn 102, Issue 1, 2008, Pages 55-59

  Cheng, Zhongping ^a   Xie, Yan ^a   Dai, Hong ^a   Hu, Liping ^a   Zhu, Yu ^a   Gong, Jun ^a  

^a Tongji University School of Medicine   (China)

Author keywords

Myoma; Plasminogen activator inhibitor type 1; Tissue plasminogen activator; Urokinase plasminogen activator; Uterine artery occlusion

Indexed keywords

MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ADULT; ARTERY OCCLUSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL; TUMOR NECROSIS; UTERINE ARTERY; UTERUS MYOMA;

EID: 46549089812     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2008.02.006     Document Type: Article

References (15)

1. Stewart E.A. Uterine fibroids. Lancet 357 (2001) 293-298
2. Walker C.L., and Stewart E.A. Uterine fibroids: the elephant in the room. Science 308 (2005) 1589-1592
3. Guarnaccia M.M., and Rein M.S. Traditional surgical approaches to uterine fibroids: abdominal myomectomy and hysterectomy. Clin Obstet Gynecol 44 (2001) 385-400
4. Ravina J.H., Bouret J.M., Fried D., Benifla J.L., Daraï E., Pennéhouat G., et al. Value of preoperative embolization of uterine fibroma: report of a multicenter series of 31 cases. Contracept Fertil Sex 23 (1995) 45-49
5. Burbank F., and Hutchins F.L. Uterine artery occlusion by embolization or surgery for the treatment of fibroids: a unifying hypothesis-transient uterine ischemia. J Am Assoc Gynecol Laparosc 7 (2000) S1-S49 [suppl]
6. Brahma P.K., Martel K.M., and Christman G.M. Future directions in myoma research. Obstet Gynecol Clin North Am 33 (2006) 199-224
7. Holub Z., Eim J., Jabor A., Hendl A., Lukac J., and Kliment L. Complications and myoma recurrence after laparoscopic uterine artery occlusion for symptomatic myomas. J Obstet Gynecol Res 32 (2006) 55-62
8. Lichtinger M., Halson L., Calvo P., Hallson L., Calvo P., and Adeboyejo G. Laparoscopic uterine artery occlusion for symptomatic leiomyomas. J Am Assoc Gynecol Laparosc 9 2 (2002) 191-198
9. Hald K., Langebrekke A., Klow N.E., Noreng H.J., Berge A.B., and Istre O. Laparoscopic occlusion of uterine vessels for the treatment of symptomatic fibroids: initial experience and comparison to uterine artery embolization. Am J Obstet Gynecol 190 1 (2004) 37-43
10. Burbank F. Childbirth and myoma treatment by uterine artery occlusion: do they share a common biology?. J Am Assoc Gynecol Laparosc 11 2 (2004) 138-152
11. Nikolic B., Kessler C.M., Jacobs H.M., Abbara S., Ammann A.M., and Neeman Z. Changes in blood coagulation markers associated with uterine artery embolization for leiomyomata. J Vasc Interv Radiol 14 9 pt 1 (2003) 1147-1153
12. Dano K., Behrendt N., Hoyer-Hansen G., Johnsen M., Lund L.R., Ploug M., et al. Plasminogen activation and cancer. Thromb Haemost 93 4 (2005) 676-681
13. Lwaleed B.A., Greenfield R., Stewart A., Birch B., and Cooper A.J. Seminal clotting and fibrinolytic balance: a possible physiological role in the male reproductive system. Thromb Haemost 92 (2004) 752-766
14. Blasi F. Proteolysis, cell adhesion, chemotaxis, and invasiveness are regulated by the uPA-uPAR-PAI-1 system. Thromb Haemost 82 (1999) 298-304
15. Kohier H.P., and Grant P.J. Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med 342 (2000) 1792-1801